Oncternal Therapeutics Shares Are Trading Lower After the Company Announced It Will Discontinue Its Clinical Trials for ONCT-535 and ONCT-808 Due to a Lack of Meaningful Results and High Capital Requirements.
Oncternal Therapeutics Shares Are Trading Lower After the Company Announced It Will Discontinue Its Clinical Trials for ONCT-535 and ONCT-808 Due to a Lack of Meaningful Results and High Capital Requirements.
oncternal therapeutics宣佈將停止ONCt-535和ONCt-808的臨床試驗，原因是缺乏意義深遠的結果和高額資本需求，其股價已經下跌。
Oncternal Therapeutics Shares Are Trading Lower After the Company Announced It Will Discontinue Its Clinical Trials for ONCT-535 and ONCT-808 Due to a Lack of Meaningful Results and High Capital Requirements.
由於缺乏有意義的結果和較高的資本要求，Oncternal Therapeutics宣佈將停止對ONCT-535和ONCT-808的臨床試驗，此後，該公司股價走低。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間